rs587781250
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM5PP3_Moderate
The NM_001540.5(HSPB1):c.380G>A(p.Arg127Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R127W) has been classified as Pathogenic.
Frequency
Consequence
NM_001540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPB1 | NM_001540.5 | c.380G>A | p.Arg127Gln | missense_variant | 2/3 | ENST00000248553.7 | NP_001531.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPB1 | ENST00000248553.7 | c.380G>A | p.Arg127Gln | missense_variant | 2/3 | 1 | NM_001540.5 | ENSP00000248553.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459020Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725816
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary peripheral neuropathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Mar 30, 2023 | This sequence change is predicted to replace arginine with glutamine at codon 127 of the HSPB1 protein (p.(Arg127Gln)). The arginine residue is moderately conserved (100 vertebrates, UCSC), and is located in the alpha-crystallin domain (ACD). The residue is invariant in human heatshock proteins (PMID: 30842409). There is a small physicochemical difference between arginine and glutamine. The variant is absent in a large population cohort (gnomAD v2.1 and v3.1), and has been identified in at least 3 probands with neuropathy (Invitae, Royal Melbourne Hospital). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (6/6 algorithms). Two pathogenic variants with a larger physicochemical difference have been reported at this position (ClinVar; p.Arg217Trp, p.Arg127Leu). Based on the classification scheme RMH Modified ACMG Guidelines v1.4.0, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM1, PS4_Supporting, PM2_Supporting, PP3. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 13, 2023 | Variant summary: HSPB1 c.380G>A (p.Arg127Gln) results in a conservative amino acid change located in the Alpha crystallin/Hsp20 domain (IPR002068) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248848 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.380G>A has been reported in the literature as a biallelic genotype in at least one individual affected with Distal Neuropathy (Lim_2022). This individual presented as a sporadic case, with no family history of disease, including 2 unaffected children confirmed to be carrying the variant of interest. Currently, Charcot-Marie-Tooth disease, axonal, type 2F (MIM 606595) and Neuronopathy, distal hereditary motor, type IIB (MIM 608634) are both considered autosomal dominant disorders. These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 35328016). Two ClinVar submitters have assessed the variant since 2014, and both classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Charcot-Marie-Tooth disease axonal type 2F Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Different missense substitutions at this codon (p.R127L, p.R127W) have been determined to be pathogenic (PMID: 26675522, 25025039, 23728742, 16215937, 22031878, 21983720, 15122254, 20178975). This suggests that the arginine residue is critical for HSPB1 protein function and that other missense substitutions at this position may also be pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with HSPB1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glutamine at codon 127 of the HSPB1 protein (p.Arg127Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at